Policies Related to the Incident:
Anti-bribery and anti-corruption (Compliance with laws, regulations and corporate guidelines related to corruption, bribery and fraud risks). Research and development (Development of new GRUPO FARMA products which are always in accordance with national and international regulations). Manufacturing and supply (Manufacturing, demand, procurement and supply management systems for goods and services is fair, equitable, transparent, competitive and profitable with ethical and legal compliance). Interaction with patients and organizations (Interactions with patients, patient organizations,and health care providers must comply with current laws and regulations, as well as the corporate standards applicable to GRUPO FARMA). Competition laws (Compliance with current Competition Laws where GRUPO FARMA operates). Safety, quality and performance of products (Guarantee the safety, quality and performance of GRUPO FARMA products in the processes related to manufacturing, marketing, distribution, sales and post-sale services, carried out by GRUPO FARMA or third parties). Pharmacovigilance policy (Guidelines for the pharmacovigilance program throughout the region must be adapted to the regulations required in each country). Patents and trademarks (Protect GRUPO FARMA’S intangible assets such as trademarks, patents, copyright and distinctive signs. This is a fundamental part of the business. Creating, processing, registering and respecting the laws of patents, distinctive signs, rights, copyright and intellectual property must coincide with current regulations and laws). Books and records maintenance (Books and records should be readily available and they must accurately and transparently reflect the transactions of GRUPO FARMA). Confidential information (The use, protection and disclosure of confidential information of GRUPO FARMA. For GRUPO FARMA, having adequate information management guarantees that only authorized persons have access, preventing those who are not authorized from putting the objectives and shareholders interest at risk). Privacy of personal data (The correct use (use, collection, circulation) of personal data in GRUPO FARMA, which includes data from patients, suppliers, customers, health professionals, GRUPO FARMA employees,employees family members, former employees and third parties in general). Conflict of interest (Guidelines so that GRUPO FARMA employees always conduct themselves with integrity and honesty, and also while always respecting the highest ethical standards of the pharmaceutical industry, and by following current regulations and GRUPO FARMA policies. Said guidelines must be followed in any situation related to business operations, with clients, suppliers, officials of any kind, among fellow collaborators, with GRUPO FARMA, and with any other third party, in order to preserve the trust in GRUPO FARMA by all the aforementioned entities).
Social media (Participation in Social Media as a role for managing any of the Company's accounts (those used exclusively for business purposes) is carried out in a respectful manner, and in accordance with the principles and values established in the Code of Ethics and Conduct of the Company). Risk management (Risk management must be transparent, ethical and done in a timely manner, in order to guarantee the fulfillment of its objectives, to protect the interests of its shareholders and to allow us to comply with legal requirements). Global commercial laws (Procedures and principles used by GRUPO FARMA to direct its actions against third parties with whom it maintains a relationship in the Pharmaceutical Industry). Licensing policy (General guidelines that will govern the performance for the use of software licensing of the automated information systems required for the development of GRUPO FARMA'S business processes). Information security (General guidelines that will govern the appropriate framework of action to safeguard GRUPO FARMA’S information required for the operation of business operating processes). No retaliation (Establishment of the bases so that in the event that any collaborator observes or suspects that there is illegal, improper or unethical conduct, they are encouraged to cooperate with internal investigations of any matter, providing honest, truthful and complete information without fear of reprisals for the generated report). Equal employment opportunity (Guidelines that promote and guarantee equal employment opportunity, non-discrimination in access to employment and equal opportunity). Discrimination and harassment (Ensure a workplace with respectful and equal treatment, without discrimination, intimidation or harassment to employees, customers, suppliers and people in general, who have relationships with GRUPO FARMA). Substance abuse (Lines of action to provide a work environment free from the consumption and abuse of alcohol and/or tobacco, as well as illicit drugs). Compliance policy (Ensure the internal and external regulatory compliance of GRUPO FARMA, thus systematizing the existing controls for the prevention and mitigation of the risks of non-compliance that may be associated with the different activities carried out by GRUPO FARMA). Corporate social responsibility (GRUPO FARMA'S commitment to ensure its management so as not to affect its shareholders. Iin addition to assuming their responsibility in the event that for any reason, something or someone could be affected). Health and environmental protection (Implications related to the spectrum of administrative and production activities of GRUPO FARMA in order to protect communities, patients, employees, customers, competition and the environment during operational management). Government investigations routine information request (Request for information or visit by government entities, in order to safeguard the assets of GRUPO FARMA). Political activity (Guidelines to the participation of GRUPO FARMA and its collaborators in political activities).
All the information received will be analyzed under strict confidentiality and reservation.
